CDKL5 and glioma: The findings of the MTT assay proved that glioma cells with CDKL5 knockdown (KD) displayed remarkably reduced proliferation in comparison with that of the control group (Fig. 3A), whereas excessive CDKL5 expression promoted cell proliferation.